Regarding prolactin and migraine treatment, dopamine agonists including bromocriptine and carbidopa/levodopa have reportedly been effective in managing migraines supposedly triggered by elevated prolactin levels by inhibiting prolactin release. The gene discussed is PRL; the disease is migraine disorder.